Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years

Cancer Causes and Control

Volumn 23, Issue 5, 2012, Pages 703-708

  Liao, Shu Fen ^a   Lee, Wen Chung ^a,b   Chen, Hui Chi ^c   Chuang, Li Chung ^c   Pan, Mei Hung ^c   Chen, Chien Jen ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Academia Sinica ^*  (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Cervical cancer; Epidemiologic methods; Human papillomavirus; Interaction causal model; Vaginal parity

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CAUSAL MODELING; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PARITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; TAIWAN; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 84862798613     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9939-4     Document Type: Article

References (25)

1. Bosch FX, de Sanjose S (2003) Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3-13
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN (2008), Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
3. Taiwan Cancer Registry. Cancer Incidence and Mortality Rates in Taiwan. [Internet]. Available at http://www.bhp.doh.gov.tw/bhpnet/portal/Statistics.
4. Waggoner SE (2003) Cervical cancer. Lancet 361:2217-2225
5. Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1-5
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265 (Pubitemid 34293391)
7. Bosch FX, de Sanjose S (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23: 213-227 (Pubitemid 47015785)
8. Steben M, Duarte-Franco E (2007) Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107:S2-S5 (Pubitemid 47559075)
9. Koutsky LA, Holmes KK, Critchlow CW et al (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272-1278
10. Sherman ME, Lorincz AT, Scott DR et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95:46-52 (Pubitemid 36124295)
11. Woodman CB, Collins S, Winter H et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831-1836 (Pubitemid 32539115)
12. Hildesheim A, Herrero R, Castle PE et al (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219-1226 (Pubitemid 32511340)
13. Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20-28
14. Castellsague X, Bosch FX, Munoz N (2002) Environmental cofactors in HPV carcinogenesis. Virus Res 89:191-199
15. Vaccarella S, Herrero R, Dai M et al (2006) Reproductive factors, oral contraceptives use, and human papillomavirus infection: pooled analysis of the IARC prevalence surveys. Cancer Epidemiol Biomarkers Prev 15:2148-2153 (Pubitemid 44877039)
16. Munoz N, Franceschi S, Bosetti C et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093-1101 (Pubitemid 34270732)
17. Louie KS, de Sanjose S, Diaz M et al (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 100:1191-1197
18. Liao SF, Lee WC (2010) Weighing the causal pies in case-control studies. Ann Epidemiol 20:568-573
19. International Agency for Research on Cancer (IARC) (2009) A review of human carcinogens-Part B: biological agents. Lancet 10:321-322
20. Lin CY, Chao A, Yang YC et al (2008) Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361-367
21. Rothman KJ (1976) Causes. Am J Epidemiol 104:587-592
22. Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA
23. Skrondal A (2003) Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 158:251-258
24. Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527 (Pubitemid 36159887)
25. Schiffman M, Castle PE, Jeronimo J, Rodriquez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890-907 (Pubitemid 47371147)